Jove
Visualize
Contact Us

Related Experiment Videos

Management of hepatitis C.

Coleman Smith1

  • 1Minnesota Gastroenterology, Minneapolis, USA.

Minnesota Medicine
|July 2, 2003
PubMed
Summary

Hepatitis C (HCV) is a common blood-borne liver disease. While current treatments can eradicate the virus in over half of patients, side effects are common, and new therapies are under investigation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Simvastatin Treatment in Patients with Liver Cirrhosis: a Phase II Randomized Placebo Controlled Trial Shows Reduction in IL-6 Levels.

Cancer prevention research (Philadelphia, Pa.)·2026
Same author

The Relentless Progression of Metabolic Dysfunction-associated Steatotic Liver Disease in Liver Transplantation in Spain.

Transplantation·2025
Same author

Risk Stratification for Chronic Kidney Disease After Liver Transplant for Metabolic Dysfunction-associated Steatohepatitis (MASH) Cirrhosis: Results From the NailMASH Consortium.

Transplantation·2024
Same author

The Survival Benefit of Reabstinence After Harmful Alcohol Use Following Early Liver Transplant for Severe Alcohol-Associated Hepatitis: A Multicenter ACCELERATE Study.

The American journal of gastroenterology·2024
Same author

Hemorrhagic Shock from a Duodenal Ulcer Eroding into an Ectopic Varix.

Case reports in hepatology·2024
Same author

Outcomes of early vs late treatment initiation in solid organ transplantation from hepatitis C virus nucleic acid test-positive donors to hepatitis C virus-uninfected recipients: Results from the HCV-TARGET study.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2023
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Virology

Background:

  • Hepatitis C virus (HCV) infection is a leading cause of liver disease.
  • Acquisition is primarily through blood exposure, often linked to injection drug use or pre-1991 transfusions.
  • Most infections become chronic, with disease progression occurring over decades.

Purpose of the Study:

  • To summarize the epidemiology, diagnosis, and treatment of Hepatitis C.
  • To highlight the effectiveness and limitations of current therapies.
  • To mention ongoing research into novel treatment modalities.

Main Methods:

  • Diagnosis involves detecting anti-HCV antibodies and confirming viremia.
  • Liver biopsy is used to assess disease severity.
  • Treatment efficacy is evaluated based on sustained viral eradication.

Main Results:

  • Pegylated interferon combined with ribavirin achieves sustained HCV eradication in over 50% of treated patients.
  • Chronic HCV infection often progresses silently for years.
  • Significant side effects can limit current treatment regimens.

Conclusions:

  • Hepatitis C virus infection requires effective management strategies.
  • Current treatments offer a high chance of viral eradication but have limitations.
  • Further research into new Hepatitis C treatments is essential.

Related Experiment Videos